Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 16.91% is in line with its 5-year average of 17.82%, around the middle of its 5-year range (8.70%–23.56%).
1.26% above its 12-month average of 16.70%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 14.24%.
EBITDA MARGIN
16.91%
EBITDA MARGIN AVG TTM
16.70%
EBITDA MARGIN AVG 3Y
18.08%
EBITDA MARGIN AVG 5Y
17.82%
EBITDA MARGIN AVG 10Y
18.41%
EBITDA MARGIN AVG 15Y
17.34%
EBITDA MARGIN AVG 20Y
16.34%
CURRENT VS TTM AVG
+1.26%
CURRENT VS 3Y AVG
-6.45%
CURRENT VS 5Y AVG
-5.12%
CURRENT VS 10Y AVG
-8.13%
CURRENT VS 15Y AVG
-2.50%
CURRENT VS 20Y AVG
+3.49%
ICON Public Limited Company
Market Cap
$12.41B
EBITDA Margin
16.91%
TTM Avg
16.70%
3Y Avg
18.08%
5Y Avg
17.82%
Market Cap
$12.14B
EBITDA Margin
5.99%
TTM Avg
7.75%
3Y Avg
3.55%
5Y Avg
8.89%
Market Cap
$11.88B
EBITDA Margin
23.27%
TTM Avg
22.46%
3Y Avg
26.66%
5Y Avg
22.37%
Market Cap
$13.43B
EBITDA Margin
-11.84%
TTM Avg
-53.07%
3Y Avg
-52.51%
5Y Avg
-64.32%
Market Cap
$11.34B
EBITDA Margin
28.74%
TTM Avg
23.07%
3Y Avg
27.33%
5Y Avg
30.04%
Market Cap
$11.10B
EBITDA Margin
27.02%
TTM Avg
27.38%
3Y Avg
26.41%
5Y Avg
26.36%
Market Cap
$13.98B
EBITDA Margin
22.69%
TTM Avg
18.62%
3Y Avg
20.95%
5Y Avg
21.80%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ICON Public Limited Company (ICLR) | $12.41B | 16.91% | 16.70% | 18.08% | 17.82% |
| Penumbra, Inc. (PEN)vs › | $12.51B | 14.73% | 11.96% | 9.26% | 5.60% |
| Baxter International Inc. (BAX)vs › | $12.14B | 5.99% | 7.75% | 3.55% | 8.89% |
| Encompass Health Corporation (EHC)vs › | $11.88B | 23.27% | 22.46% | 26.66% | 22.37% |
| DaVita Inc. (DVA)vs › | $11.47B | 19.98% | 20.97% | 19.78% | 20.10% |
| Tempus AI, Inc. (TEM)vs › | $13.43B | -11.84% | -53.07% | -52.51% | -64.32% |
| Bio-Techne Corporation (TECH)vs › | $11.34B | 28.74% | 23.07% | 27.33% | 30.04% |
| The Cooper Companies, Inc. (COO)vs › | $11.10B | 27.02% | 27.38% | 26.41% | 26.36% |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.98B | 22.69% | 18.62% | 20.95% | 21.80% |
| Universal Health Services, Inc. (UHS)vs › | $10.64B | 15.05% | 14.69% | 13.35% | 14.10% |
Gross Margin
21.9%
EBITDA Margin
16.9%
Operating Margin
10.2%
Net Margin
4.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 14.24% |
| 2026-03-31 | 12.98% |
| 2025-12-31 | 23.56% |
| 2025-09-30 | 17.50% |
| 2025-06-30 | 15.21% |
| 2025-03-31 | 15.77% |
| 2024-12-31 | 19.29% |
| 2024-09-30 | 18.64% |
| 2024-06-30 | 17.90% |
| 2024-03-31 | 20.79% |
| 2023-12-31 | 20.47% |
| 2023-09-30 | 20.47% |
| 2023-06-30 | 18.16% |
| 2023-03-31 | 18.86% |
| 2022-12-31 | 18.12% |
| 2022-09-30 | 19.85% |
| 2022-06-30 | 16.63% |
| 2022-03-31 | 16.39% |
| 2021-12-31 | 15.86% |
| 2021-09-30 | 8.70% |
| 2021-06-30 | 15.73% |
| 2021-03-31 | 16.38% |
| 2020-12-31 | 18.02% |
| 2020-09-30 | 17.84% |
| 2020-06-30 | 11.74% |
| 2020-03-31 | 17.15% |
| 2019-12-31 | 18.06% |
| 2019-09-30 | 18.72% |
| 2019-06-30 | 18.54% |
| 2019-03-31 | 18.51% |
| 2018-12-31 | 17.19% |
| 2018-09-30 | 17.56% |
| 2018-06-30 | 15.42% |
| 2018-03-31 | 17.52% |
| 2017-12-31 | 23.27% |
| 2017-09-30 | 22.99% |
| 2017-06-30 | 21.44% |
| 2017-03-31 | 23.18% |
| 2016-12-31 | 23.00% |
| 2016-09-30 | 21.81% |
| 2016-06-30 | 21.52% |
| 2016-03-31 | 22.75% |
| 2015-12-31 | 22.43% |
| 2015-09-30 | 21.72% |
| 2015-06-30 | 21.19% |
| 2015-03-31 | 20.76% |
| 2014-12-31 | 16.91% |
| 2014-09-30 | 18.88% |
| 2014-06-30 | 16.28% |
| 2014-03-31 | 15.60% |
| 2013-12-31 | 14.68% |
| 2013-09-30 | 13.17% |
| 2013-06-30 | 11.32% |
| 2013-03-31 | 10.88% |
| 2012-12-31 | 11.66% |
| 2012-09-30 | 11.02% |
| 2012-06-30 | 9.47% |
| 2012-03-31 | 8.93% |
| 2011-12-31 | 7.16% |
| 2011-09-30 | 6.56% |
| 2011-06-30 | 10.66% |
| 2011-03-31 | 12.98% |
| 2010-12-31 | 13.31% |
| 2010-09-30 | 11.38% |
| 2010-06-30 | 15.18% |
| 2010-03-31 | 16.20% |
| 2009-12-31 | 13.21% |
| 2009-09-30 | 17.61% |
| 2009-06-30 | 12.68% |
| 2009-03-31 | 15.65% |
| 2008-12-31 | 15.23% |
| 2008-09-30 | 15.55% |
| 2008-06-30 | 14.23% |
| 2008-03-31 | 13.70% |
| 2007-12-31 | -180.44% |
| 2007-09-30 | 14.19% |
| 2007-06-30 | 13.93% |
| 2007-03-31 | 13.83% |
| 2006-12-31 | 13.73% |
| 2006-09-30 | 13.64% |
| 2006-06-30 | 13.96% |
| 2006-03-31 | 13.69% |
| 2005-11-30 | 14.51% |
| 2005-08-31 | 14.03% |
| 2005-05-31 | 12.98% |
| 2005-02-28 | -2.25% |
| 2004-11-30 | -7.58% |
| 2004-08-31 | 15.96% |
| 2004-05-31 | 17.49% |
| 2004-02-29 | 15.15% |
| 2003-11-30 | 15.15% |
| 2003-08-31 | 14.80% |
| 2003-05-31 | 14.39% |
| 2003-02-28 | 13.57% |
| 2002-11-30 | 14.69% |
| 2002-08-31 | 14.48% |
